Neptune Wellness Solutions Inc.

2024 Q1 Form 10-Q Financial Statement

#000143774924004627 Filed on February 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.251M
YoY Change -63.22%
Cash & Equivalents $1.233M
Short-Term Investments $17.64K
Other Short-Term Assets $1.840M
YoY Change -36.56%
Inventory $9.616M
Prepaid Expenses $1.840M
Receivables $3.893M
Other Receivables $0.00
Total Short-Term Assets $16.60M
YoY Change -41.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.035M
YoY Change -44.41%
Goodwill $2.483M
YoY Change -82.75%
Intangibles $1.309M
YoY Change -92.45%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.426M
YoY Change -82.02%
TOTAL ASSETS
Total Short-Term Assets $16.60M
Total Long-Term Assets $6.426M
Total Assets $23.03M
YoY Change -64.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.37M
YoY Change 42.6%
Accrued Expenses $339.6K
YoY Change -32.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $25.98M
YoY Change
Total Short-Term Liabilities $73.42M
YoY Change 145.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $14.00K
YoY Change -39.13%
Total Long-Term Liabilities $14.00K
YoY Change -99.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.42M
Total Long-Term Liabilities $14.00K
Total Liabilities $75.25M
YoY Change 56.62%
SHAREHOLDERS EQUITY
Retained Earnings -$383.6M
YoY Change 7.42%
Common Stock $387.6M
YoY Change 2.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$31.25M
YoY Change
Total Liabilities & Shareholders Equity $23.03M
YoY Change -64.0%

Cashflow Statement

Concept 2024 Q1 2023 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Neptune Wellness Solutions Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001401395
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4532038
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4532038
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
300070
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
300070
CY2023Q4 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 usd
CY2022Q4 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
643476 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2023Q4 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2022Q4 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2023Q4 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0 usd
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33526
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A8
dei Entity Address Address Line1
EntityAddressAddressLine1
545 Promenade du Centropolis, Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Laval
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
H7T 0A3
dei City Area Code
CityAreaCode
450
dei Local Phone Number
LocalPhoneNumber
687-2262
dei Security12b Title
Security12bTitle
Common shares, no par value
dei Trading Symbol
TradingSymbol
NEPT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4532038
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1232905 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1993257 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
17642 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
17540 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3893358 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
7507333 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1839657 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1025969 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
9616172 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
13006074 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16599734 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
23550173 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1035423 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1403264 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1599231 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1941347 usd
CY2023Q4 nept Royalty Revenues
RoyaltyRevenues
23963 usd
CY2022Q4 nept Royalty Revenues
RoyaltyRevenues
263816 usd
nept Royalty Revenues
RoyaltyRevenues
70961 usd
nept Royalty Revenues
RoyaltyRevenues
766736 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1308849 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1607089 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2482706 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2426385 usd
CY2023Q4 us-gaap Assets
Assets
23025943 usd
CY2023Q1 us-gaap Assets
Assets
30928258 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31371563 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
27051561 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
339620 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
339620 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
25984400 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7538369 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
14809758 usd
CY2023Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
2948340 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
911790 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3156254 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73417131 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
41034144 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1816377 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2017888 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15412895 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
75247508 usd
CY2023Q1 us-gaap Liabilities
Liabilities
58488927 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
327944215 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
321946102 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6648437 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6155323 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
59681063 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
58138914 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14925620 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14538830 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-410595259 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-383641363 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31247164 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11939854 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-20974401 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-15620815 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-52221565 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-27560669 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23025943 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30928258 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7611836 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11945092 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26913567 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39668246 usd
CY2023Q4 us-gaap Other Income
OtherIncome
-36047 usd
CY2022Q4 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
-17071 usd
us-gaap Other Income
OtherIncome
32996 usd
CY2023Q4 us-gaap Revenues
Revenues
7599752 usd
CY2022Q4 us-gaap Revenues
Revenues
12208908 usd
us-gaap Revenues
Revenues
26967457 usd
us-gaap Revenues
Revenues
40467978 usd
CY2023Q4 us-gaap Direct Operating Costs
DirectOperatingCosts
6564684 usd
CY2022Q4 us-gaap Direct Operating Costs
DirectOperatingCosts
10328349 usd
us-gaap Direct Operating Costs
DirectOperatingCosts
24941822 usd
us-gaap Direct Operating Costs
DirectOperatingCosts
37293901 usd
CY2023Q4 us-gaap Inventory Write Down
InventoryWriteDown
-0 usd
CY2022Q4 us-gaap Inventory Write Down
InventoryWriteDown
-0 usd
us-gaap Inventory Write Down
InventoryWriteDown
216184 usd
us-gaap Inventory Write Down
InventoryWriteDown
3079997 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6564684 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10328349 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25158006 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
40373898 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
1035068 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
1880559 usd
us-gaap Gross Profit
GrossProfit
1809451 usd
us-gaap Gross Profit
GrossProfit
94080 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
727 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28836 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47266 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
451121 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18732654 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8727323 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34541474 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35188695 usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
-0 usd
CY2022Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
-0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
-0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2593529 usd
CY2023Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
-0 usd
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
-0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
-0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
15346119 usd
CY2023Q4 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
-0 usd
CY2022Q4 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
271057 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
75409 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
271057 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 usd
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7570471 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
84998 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
170000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-17698313 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7061659 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32854698 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-61156912 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
2066405 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
-0 usd
us-gaap Restructuring Charges
RestructuringCharges
2066405 usd
us-gaap Restructuring Charges
RestructuringCharges
-0 usd
CY2023Q4 nept Finance Income
FinanceIncome
0 usd
CY2022Q4 nept Finance Income
FinanceIncome
0 usd
nept Finance Income
FinanceIncome
0 usd
nept Finance Income
FinanceIncome
1440 usd
CY2023Q4 nept Finance Costs
FinanceCosts
1602981 usd
CY2022Q4 nept Finance Costs
FinanceCosts
1362776 usd
nept Finance Costs
FinanceCosts
6570787 usd
nept Finance Costs
FinanceCosts
2658305 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
600316 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
524571 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
942596 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6545401 usd
CY2023Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2022Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1029614 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-945034 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-3156569 usd
CY2023Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1596901 usd
CY2022Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
8367871 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
7186846 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
16083681 usd
CY2023Q4 nept Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
0 usd
CY2022Q4 nept Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
66169 usd
nept Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
0 usd
nept Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
66169 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1472169 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6566221 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1452784 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16881817 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19170482 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-495438 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34307482 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44275095 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2013 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14543 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-19170482 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-497451 usd
us-gaap Profit Loss
ProfitLoss
-34307482 usd
us-gaap Profit Loss
ProfitLoss
-44289638 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41449 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-231490 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-386790 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6725131 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-41449 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-231490 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-386790 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6725131 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19211931 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-728941 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34694272 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-51014769 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-17749338 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1288110 usd
us-gaap Net Income Loss
NetIncomeLoss
-26953896 usd
us-gaap Net Income Loss
NetIncomeLoss
-33893698 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1421144 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1785561 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7353586 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10395940 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-19170482 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-497451 usd
us-gaap Profit Loss
ProfitLoss
-34307482 usd
us-gaap Profit Loss
ProfitLoss
-44289638 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17790787 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1056620 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27340686 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40618829 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1421144 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1785561 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-7353586 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-10395940 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19211931 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-728941 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34694272 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-51014769 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.14
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-143
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.14
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-143
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4285229
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284619
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1784047
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237013
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4285229
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
284690
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1784047
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237013
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-27560669 usd
us-gaap Profit Loss
ProfitLoss
-34307482 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-386790 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34694272 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1516920 usd
nept Stock Issued During Period Value Settlement Of Litigation
StockIssuedDuringPeriodValueSettlementOfLitigation
2750000 usd
nept Warrants Issued During Period For Restructuring
WarrantsIssuedDuringPeriodForRestructuring
2066404 usd
nept Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
696 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3699356 usd
nept Stockholders Equity Period Increase Decrease Contributions And Distributions
StockholdersEquityPeriodIncreaseDecreaseContributionsAndDistributions
10033376 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-52221565 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-38259532 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-19170482 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-41449 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19211931 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
433494 usd
CY2023Q4 nept Stock Issued During Period Value Litigation Settlement
StockIssuedDuringPeriodValueLitigationSettlement
2750000 usd
CY2023Q4 nept Warrants Issued During Period For Restructuring
WarrantsIssuedDuringPeriodForRestructuring
2066404 usd
CY2023Q4 nept Stockholders Equity Period Increase Decrease Contributions And Distributions
StockholdersEquityPeriodIncreaseDecreaseContributionsAndDistributions
5249898 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-52221565 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
15346119 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
75409 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
271057 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2593529 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60837599 usd
us-gaap Profit Loss
ProfitLoss
-44289638 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6725131 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-51014769 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2832438 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
645921 usd
nept Reclassification Of Warrants From Liability
ReclassificationOfWarrantsFromLiability
37710 usd
nept Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1769000 usd
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
815954 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
nept Stockholders Equity Period Increase Decrease Contributions And Distributions
StockholdersEquityPeriodIncreaseDecreaseContributionsAndDistributions
6101023 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15923853 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15596395 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-497451 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-231490 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-728941 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1005455 usd
CY2022Q4 nept Reclassification Of Warrants From Liability
ReclassificationOfWarrantsFromLiability
37710 usd
CY2022Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
13234 usd
CY2022Q4 nept Stockholders Equity Period Increase Decrease Contributions And Distributions
StockholdersEquityPeriodIncreaseDecreaseContributionsAndDistributions
1056399 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15923853 usd
us-gaap Profit Loss
ProfitLoss
-34307482 usd
us-gaap Profit Loss
ProfitLoss
-44289638 usd
us-gaap Depreciation
Depreciation
449166 usd
us-gaap Depreciation
Depreciation
652196 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
255270 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
385800 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
286963 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1352787 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7570471 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1516920 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2832438 usd
us-gaap Inventory Write Down
InventoryWriteDown
216184 usd
us-gaap Inventory Write Down
InventoryWriteDown
3079997 usd
us-gaap Restructuring Charges
RestructuringCharges
2066405 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
145551 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
496846 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-945034 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-3156569 usd
nept Finance Expense Net
FinanceExpenseNet
6570787 usd
nept Finance Expense Net
FinanceExpenseNet
2656865 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
180978 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
6545401 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
0 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
1440 usd
us-gaap Interest Paid Net
InterestPaidNet
2027322 usd
us-gaap Interest Paid Net
InterestPaidNet
215019 usd
nept Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
-0 usd
nept Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
66169 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
7186846 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
16083681 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
209194 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
253795 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14543 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
170000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-23819010 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
3121778 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79208 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
601743 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79208 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2690035 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
30921043 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
30917703 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-6543514 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
0 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-360 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7565123 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20669892 usd
us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 usd
us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
170000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3800000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
574153 usd
nept Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
8499845 usd
nept Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
5000002 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6000002 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1521640 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1330211 usd
nept Proceeds From Option And Warrant Exercises
ProceedsFromOptionAndWarrantExercises
696 usd
nept Proceeds From Option And Warrant Exercises
ProceedsFromOptionAndWarrantExercises
65 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6975561 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12895705 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-91582 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-238166 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-760352 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5322318 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1993257 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8726341 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1232905 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3404023 usd
CY2023Q4 us-gaap Cash
Cash
1232905 usd
CY2022Q4 us-gaap Cash
Cash
3404023 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3954320 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2489793 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1746741 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-798493 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3032798 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2544635 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6727215 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1599623 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-285006 usd
nept Increase Decrease In Litigation Reserve
IncreaseDecreaseInLitigationReserve
11861418 usd
nept Increase Decrease In Litigation Reserve
IncreaseDecreaseInLitigationReserve
4550934 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-65688 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-23819010 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-6543514 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
198000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5700000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24100000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600000
us-gaap Profit Loss
ProfitLoss
-34300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7600000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-410600000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-88800000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28600000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 27pt; font-size: 8pt;"> <p style="margin: 0pt; text-align: justify; font-family: Calibri, Arial, sans-serif; font-size: 8pt;"><b><em style="font: inherit;">2.</em></b></p> </td><td style="width: auto; font-size: 8pt;"> <p style="margin: 0pt; text-align: justify; font-family: Calibri, Arial, sans-serif; font-size: 8pt;"><b>Basis of preparation: </b></p> </td></tr> </tbody></table> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 45pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">(a)</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Accounting framework:</p> </td></tr> </tbody></table> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">These condensed consolidated interim financial statements have been prepared in accordance with United States generally accepted accounting principles (U. S. GAAP) as codified in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC).</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 45pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">(b)</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Functional and reporting currency:</p> </td></tr> </tbody></table> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">Effective <em style="font: inherit;"> March 31, 2022, </em>the Company changed its reporting currency from Canadian dollars (“CAD”) to U.S. dollars (“USD”). This change in reporting currency has been applied retroactively such that all amounts in the consolidated financial statements of the Company and the accompanying notes thereto are expressed in U.S. dollars. References to "$" and "USD" are U.S dollars and references to “CAD $” and "CAD" are to Canadian dollars. For comparative purposes, historical consolidated financial statements were recast in U.S. dollars by translating (i) assets and liabilities at the closing exchange rate in effect at the end of the respective period, (ii) revenues, expenses and cash flows at the average exchange rate in effect for the respective period and (iii) equity transactions at historical exchange rates. Translation gains and losses are included as part of the cumulative foreign currency translation adjustment, which is reported as a component of shareholders’ equity under accumulated other comprehensive loss.</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">The assets and liabilities of foreign operations with a functional currency other than the U.S. dollar are translated into U.S. dollars at the exchange rate in effect at the balance sheet date. Revenue and expenses are translated at the monthly average exchange rates for the period. Differences arising from the exchange rate changes are recorded within foreign currency translation adjustments, a component of other comprehensive income (loss).</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">Transactions in foreign currencies are translated to the respective functional currencies of the Company’s subsidiaries at the average exchange rates for the period. The monetary items denominated in currencies other than the functional currency of a subsidiary are translated at the exchange rates prevailing at the balance sheet date. Non-monetary items denominated in currencies other than the functional currency are translated at historical rates. Gains and losses resulting from re-measurement are recorded in the Company’s condensed consolidated interim statement of loss and comprehensive loss as foreign exchange gain (loss).</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">As a result of the divestiture of its Canadian cannabis business, a significant portion of its remaining revenues, expenses, assets and liabilities are denominated in US dollars. In addition, and as a result of the increasing operations in the U.S., Neptune changed its functional currency from Canadian dollars (“CAD”) to U.S. dollars (“USD”), effective <em style="font: inherit;"> October 1, 2022. </em>This change in functional currency has been applied prospectively from the date of the change.</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">All assets and liabilities were reported using the same USD values as previously reported under the USD reporting currency described above. The cumulative translation account in Neptune was effectively frozen and the accumulated balance as at <em style="font: inherit;"> September 30, 2022 </em>is carried forward. Changes in the cumulative translation account after <em style="font: inherit;"> October 1, 2022 </em>relate to conversion of subsidiary financial statements whose functional currency is <em style="font: inherit;">not</em> USD. As of <em style="font: inherit;"> October 1, 2022, </em>the <em style="font: inherit;">2020</em> Warrants and <em style="font: inherit;">2021</em> Warrants <em style="font: inherit;">no</em> longer met the criteria for liability classification as a result of the change in functional currency and therefore were reclassified to equity on this date (see notes <em style="font: inherit;">11</em>(f) and <em style="font: inherit;">13</em>).</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 45pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">(c)</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Use of estimates:</p> </td></tr> </tbody></table> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">The preparation of the condensed consolidated interim financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities at the date of the condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results <em style="font: inherit;"> may </em>differ from the estimates made by management.</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">Estimates are based on management’s best knowledge of current events and actions that the Company <em style="font: inherit;"> may </em>undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;"> </p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;">Estimates include the following:</p> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the write down of inventory.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating expected credit losses for receivables.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the recoverable amount of non-financial assets, to determine and measure impairment losses on goodwill, intangibles, and property, plant and equipment.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the lease term of contracts with extension options and termination options.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;">●</td><td style="width: auto; font-size: 8pt; font-family: Calibri, Arial, sans-serif;">Estimating the lease liabilities and related right-of-use assets.</td></tr> <tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the revenue from contracts with customers subject to variable consideration.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the fair value of bonus, options and warrants that are based on market and non-market conditions (note <em style="font: inherit;">13</em>).</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the fair value of the identifiable assets acquired, liabilities assumed, and consideration transferred of the acquired business, including the related contingent consideration and call option.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 8pt;"><tbody><tr style="vertical-align: top; font-size: 8pt;"><td style="width: 81pt; font-size: 8pt;"> </td><td style="width: 27pt; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">●</p> </td><td style="width: auto; font-size: 8pt;"> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Estimating the litigation provision as it depends upon the outcome of proceedings (note <em style="font: inherit;">9</em>).</p> </td></tr> </tbody></table> <p style="font-family: Calibri, Arial, sans-serif; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;"> </p>
CY2023Q4 us-gaap Restructuring Costs
RestructuringCosts
2066405 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5126337 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5314450 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
98727 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4186124 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7360850 usd
CY2023Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
204984 usd
CY2023Q1 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
330774 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
9616172 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
13006074 usd
us-gaap Inventory Write Down
InventoryWriteDown
216184 usd
us-gaap Inventory Write Down
InventoryWriteDown
3079997 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
3203557 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
15346119 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2482706 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2426385 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
25984400 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
22951264 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
25984400 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7538369 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15412895 usd
CY2023Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
876436 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
4116994 usd
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
311679 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
786311 usd
CY2023Q4 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
278386 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
655132 usd
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
138606 usd
CY2022Q4 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0 usd
CY2023Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
729.32
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10443
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1496.49
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7385
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
64.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5744
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
100.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2978
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
640
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1650
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
-0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2028.4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
956
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
975.98
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7465
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
742
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10523
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
995.86
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6971
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1570
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3258
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y9M14D
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
7465
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
6971
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
995.86
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2894479
CY2023Q4 nept Class Of Warrant Or Right Participating
ClassOfWarrantOrRightParticipating
2794794
CY2023Q4 nept Class Of Warrant Or Right Nonparticipating
ClassOfWarrantOrRightNonparticipating
99685
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-17749338 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1288110 usd
us-gaap Net Income Loss
NetIncomeLoss
-26953896 usd
us-gaap Net Income Loss
NetIncomeLoss
-33893698 usd
CY2023Q4 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022Q4 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-620910 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17749338 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
667200 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26953896 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33893698 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4285229
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284619
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1784047
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237013
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
71
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4285229
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
284690
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1784047
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237013
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.14
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-143
CY2023Q4 us-gaap Revenues
Revenues
7599752 usd
CY2022Q4 us-gaap Revenues
Revenues
12208908 usd
us-gaap Revenues
Revenues
26967457 usd
us-gaap Revenues
Revenues
40467978 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1035423 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1403264 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1308849 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1607089 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2482706 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2426385 usd

Files In Submission

Name View Source Status
0001437749-24-004627-index-headers.html Edgar Link pending
0001437749-24-004627-index.html Edgar Link pending
0001437749-24-004627.txt Edgar Link pending
0001437749-24-004627-xbrl.zip Edgar Link pending
ex_598565.htm Edgar Link pending
ex_598566.htm Edgar Link pending
ex_598567.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nept-20231231.xsd Edgar Link pending
nept20230930_10qimg001.jpg Edgar Link pending
nept20230930_10qimg002.jpg Edgar Link pending
nept20230930_10qimg003.jpg Edgar Link pending
nept20230930_10qimg004.jpg Edgar Link pending
nept20231117_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
nept-20231231_cal.xml Edgar Link unprocessable
nept-20231231_def.xml Edgar Link unprocessable
nept-20231231_lab.xml Edgar Link unprocessable
nept20231117_10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nept-20231231_pre.xml Edgar Link unprocessable